Wed, Apr 23, 2014, 3:17 AM EDT - U.S. Markets open in 6 hrs 13 mins

Recent

% | $
Quotes you view appear here for quick access.

Macy's, Inc. Message Board

agentkq2 2 posts  |  Last Activity: Feb 11, 2014 8:44 AM Member since: Sep 1, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Too hard on the Pancreas

    by agentkq2 Feb 10, 2014 9:02 PM
    agentkq2 agentkq2 Feb 11, 2014 8:44 AM Flag

    You would have to be #$%$ not to take some profits or sell completely after a 145% rise in stock price. You would also have to be , and I will use a more appropriate word .... crazy...crazy to short this stock when the float is so small. All the better if no one agreess with me. Just watch how fast your paper profits will disapper.

  • I think the FDA will say eluxadoline is too hard on the pancreas, and will need more study. The pancreas is a very critical organ and one of the hardest to treat for disease. The risk will be too high. The pancreas is an endocrine gland producing several important hormones including insulin, glucagon, somatostatin, and pancreatic polypeptide which circulate in the blood.
    An insider just sold $13 million dollars worth of stock.
    Because the float is so small you should not short this stock, the upside is also small and FORX will report a fair size loss on March 11th. . If the drug gets approved which is not likely, then it will not be on the market until late 2106 , perhaps more like 2017.
    Put your money somewhere else, there are alot more other companies that will offer you a better return with a lot less risk.
    If you are in the money with this stock you should take it.

    Good luck, nobody like to loose money. Approval not likely for eluxadoline.

M
57.52+0.19(+0.33%)Apr 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSTue, Apr 22, 2014 4:00 PM EDT
Allergan Inc.
NYSETue, Apr 22, 2014 4:00 PM EDT
GW Pharmaceuticals plc
NasdaqGMTue, Apr 22, 2014 4:00 PM EDT